Fifteen million individuals in the developed world are living with a silent brain aneurysm. Every year 100,000 of those aneurysms rupture resulting in the immediate death of 50,000 people.
A brain aneurysm is a very serious condition and it is currently on the rise. A shift in demographic trends towards an older population and the increase in using noninvasive neuroimaging modalities in the outpatient setting have led to a sharp increase in the number of truly asymptomatic, incidental unruptured intracranial aneurysms diagnosed each year.
The ideal treatment of a cerebral aneurysm is exclusion from the circulation either by performing aneurysm clipping, a surgical procedure that requires creating an opening in the skull through which the surgeon inserts his instruments and places a clip across the neck of the aneurysm, or by using a less invasive endovascular approach.
Currently, over 60% of aneurysms are treated with surgical clipping and less than 40% are treated with endovascular means. This is due to the fact that the current endovascular approach which fills the aneurismal sac with embolic coils is expensive, difficult to perform and cannot be applied to all types or sizes of cerebral aneurysms.
Cardiatis Multilayer technology platform promises to change this situation. Cardiatis self-expanding braided stent easily bridges the neck of difficult to reach cerebral aneurysms and its three dimensional structure modulates hemodynamic flow within the affected artery in a way that reduces pressure within the aneurysm and slows blood flow through its vortex thus allowing a thrombus to form and the aneurysm to close physiologically.